Why is Indrapr.Medical falling/rising?

As of 25-Jul, Indraprastha Medical Corporation Ltd is experiencing a decline in its stock price, currently at 458.25, reflecting a decrease of 9.3 points or 1.99%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 5.89% over that period. Today's trading saw the stock touch an intraday low of Rs 456.3, with a weighted average price indicating that more volume was traded closer to this low. Additionally, investor participation has decreased, with delivery volume dropping by 30.31% compared to the five-day average. Despite these recent challenges, the company has demonstrated strong long-term growth, with a healthy operating profit growth rate of 30.21% and consistent positive results over the last 12 quarters, which may provide some support for the stock's valuation.
In the broader market context, the stock's short-term performance has significantly lagged behind the benchmark, with a 1-week return of -5.89% compared to the Sensex's decline of only 0.36%. However, over the longer term, the stock has outperformed the benchmark with a 69.88% return over the past year, while the Sensex has only increased by 1.78%. This disparity highlights the stock's potential for recovery, given its strong historical performance and management efficiency, as evidenced by a high return on equity and a favorable PEG ratio. Nonetheless, the recent price decline suggests that investors may be cautious in the short term, influenced by the recent drop in trading volume and consecutive losses.